RXL – ProShares Ultra Health Care
ProShares Ultra Health Care (RXL) is a Trading--Leveraged Equity ETF, issued by ProShares, $91.7M in assets, 0.95% expense ratio.
Returns as of Oct 23, 2026: 1 week +2.7%, 1 year +16.6%.
Aims for daily returns consistent with health care sector index. Invests in various health-related industries.
Top holdings
- LLY – Eli Lilly and Company, 10.6%
- JNJ – Johnson & Johnson, 6.8%
- ABBV – AbbVie Inc, 4.9%
- UNH – UnitedHealth Group Incorporated, 3.9%
- MRK – Merck & Company Inc, 3.5%
- TMO – Thermo Fisher Scientific Inc, 3.0%
- ABT – Abbott Laboratories, 2.7%
- ISRG – Intuitive Surgical Inc, 2.4%
- AMGN – Amgen Inc, 2.3%
- GILD – Gilead Sciences Inc, 2.0%
- DHR – Danaher Corporation, 1.9%
- PFE – Pfizer Inc, 1.9%
- BSX – Boston Scientific Corp, 1.7%
- SYK – Stryker Corporation, 1.6%
- MDT – Medtronic PLC, 1.6%
- BMY – Bristol-Myers Squibb Company, 1.4%
- VRTX – Vertex Pharmaceuticals Inc, 1.4%
- MCK – McKesson Corporation, 1.3%
- CVS – CVS Health Corp, 1.3%
- ELV – Elevance Health Inc, 1.1%
- HCA – HCA Holdings Inc, 1.0%
- REGN – Regeneron Pharmaceuticals Inc, 0.9%
- CI – Cigna Corp, 0.9%
- COR – Cencora Inc., 0.9%
- BDX – Becton Dickinson and Company, 0.8%